Related Experiment Video
Updated: Jan 17, 2026
Biodegradable Magnesium Stent Treatment of Saccular Aneurysms in a Rat Model - Introduction of the Surgical Technique
Published on: October 1, 2017
Late Thrombosis of First-Generation Bioresorbable Scaffold Site Treated With Novel Resorbable Magnesium Scaffold
Jorgo Kostov1, Biljana Zafirovska1, Sasko Kedev1
1Faculty of Medicine, University Clinic of Cardiology, University of St Cyril & Methodius, Skopje, Macedonia.
Background:
To the best of our knowledge, this is the first reported experience of a patient with late thrombosis of previous Absorb (Abbott Vascular) bioresorbable scaffold (BRS) implantation site, treated with second-generation Magmaris (Biotronik) resorbable magnesium scaffold (RMS).
Case Summary:
A 55-year-old man with a previously implanted Absorb BRS stent presented with a non-ST-elevation myocardial infarction. Coronary angiography showed thrombotic lesion at the BRS stent site. After intravascular optical coherence tomography (OCT) imaging, a decision was made to implant a second-generation RMS stent. OCT follow-up was performed, with excellent long-term results.
Discussion:
Randomized controlled trials have connected early BRS implantation to a higher rate of stent thrombosis. In recent years, the newer generation RMS has confirmed a good safety profile and long-term patency. The idea behind this treatment was to assess the novel RMS technology with serial OCT imaging.
Take-Home Messages:
This case adds new options for the treatment of coronary arteries with novel RMS technology. Intravascular imaging with OCT is essential for optimized treatment and follow-up.
